Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model.
about
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.Tumour tissue transport after intraperitoneal anticancer drug delivery.New Frontiers in Promoting TRAIL-Mediated Cell Death: Focus on Natural Sensitizers, miRNAs, and Nanotechnological Advancements.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imagingImplication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL.Transport of drugs from blood vessels to tumour tissue.Intravital microscopy in the study of the tumor microenvironment: from bench to human application.Tumor Microenvironment Targeted Nanotherapy
P2860
Q36791673-ADCFF057-93E9-4A45-A802-C7F2E6549FAFQ38679465-E407FF35-2EDB-4906-8DEA-3BCFF14CA978Q38772848-22867B34-5260-4C1A-8B7A-72F162FDFC45Q38776676-3FF90CCA-4D85-4E41-8EEC-AB945134017FQ42362141-77C25E3A-5CDC-42E6-9975-39017A1C3FB4Q47300891-C7DEFC72-4016-4194-9F97-35CF797E45BAQ50082408-622301FE-BB6F-4F41-8882-EF55B13C43F7Q55020615-4DB44350-C020-46E8-AD5E-B12D1635D977Q59133567-64390EFF-701A-461B-BDC4-308D090867DE
P2860
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tumor priming by Apo2L/TRAIL r ...... derived xenograft tumor model.
@ast
Tumor priming by Apo2L/TRAIL r ...... derived xenograft tumor model.
@en
type
label
Tumor priming by Apo2L/TRAIL r ...... derived xenograft tumor model.
@ast
Tumor priming by Apo2L/TRAIL r ...... derived xenograft tumor model.
@en
prefLabel
Tumor priming by Apo2L/TRAIL r ...... derived xenograft tumor model.
@ast
Tumor priming by Apo2L/TRAIL r ...... derived xenograft tumor model.
@en
P2093
P2860
P1476
Tumor priming by Apo2L/TRAIL r ...... derived xenograft tumor model.
@en
P2093
Arindam Sen
Bonnie L Hylander
Elizabeth A Repasky
Gerald J Fetterly
Jingxin Qiu
John F Gibbs
Joshua D Prey
Rose Pitoniak
Sarah H Beachy
Soumya Ullas
P2860
P304
P356
10.1016/J.JCONREL.2015.08.047
P407
P577
2015-09-02T00:00:00Z